Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Mitomycin-C and Triamcinolone for Prevention of Urethral Stricture Recurrence
IRCT20201006048950N4Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mitomycin c and triamcinolone in Urethral stenosis, sponsored by Arak University of Medical Sciences. Started Feb 2024; status: completed.
02
Drugs
mitomycin ctriamcinolone
03
Conditions
Urethral stenosis
Beyond the preview
Go deeper on IRCT20201006048950N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201006048950N4.